⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

PLSE

Pulse Biosciences, Inc.

Healthcare · Medical Instruments & Supplies

52.97USD

+4.1800 (+8.57%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 52.97
P/E—
Dvd Ind Yld—
P/B37.97
P/S3,188.2
Curr EV/T12M EBITDA-41.0
Mkt Cap (USD)3.8B
Curr EV (USD)3.4B
2)

Per Share Data

EPS T12M-1.18
DPS—
Bk Val Per Sh1.41
Rev/Sh0.03
Cash/Sh1.43
Curr Shares Out71.3M
FCF/Sh-1.65
3)

Cash Flow Analysis

P/CF-61.8
Curr P/FCF-61.5
CF/NI0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-5155.9%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr-17.4%
Cap 1Y Gr-29.8%
BPS 1Y Gr—
R&D To Sales4378.6%
Retention Rate100.0%
Rev 1Y Gr—
FCF 1Y Gr-49.3%
Assets 1Y Gr-28.6%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-7007.8%
Pretax Margin3304.4%
Net Margin-6755.8%
ROA-67.9%
ROE-78.5%
ROC-78.1%
Asset Turnover0.01
6)

Structure

Current Ratio9.63
Quick Ratio9.27
Debt/Assets5.9%
Debt/Com Eq6.8%
Net Debt/EBITDA1.15
Tot Debt/Capital6.4%
Gross Margin0.3%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.